Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/clinical-utility-of-indium-111-capromab-pendetide-immunoscintigraphy-BfNyOT7lin
References (53)
-
R. Anderson, B. Eifert, S. Tartt, P. King (2000)
Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer.Urology, 56 4
-
T. Polascik, M. Manyak, M. Haseman, R. Gurganus, B. Rogers, R. Maguire, A. Partin (1999)
Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsCancer, 85
-
D. Sodee, Ridgely Conant, M. Chalfant, Stefan Miron, Eric Klein, Robert Bahnson, J. Spirnak, Bruce Carlin, Errol Bellon, Barbara Rogers (1996)
Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer.Clinical nuclear medicine, 21 10
-
M. Anscher, R. Clough, R. Dodge (2000)
Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years.International journal of radiation oncology, biology, physics, 48 2
-
DB Sodee, N Malguria, P Faulhaber, MI Resnick, J Albert, G Bakale (2000)
Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer, 56
-
GV Raj, JG Moreno, LG Gomella (1999)
Utilization of polymerase chain reaction technology in the detection of solid tumors, 85
-
D. Kahn, Richard Williams, M. Manyak, M. Haseman, D. Seldin, J. Libertino, R. Maguire (1998)
(111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMYThe Journal of Urology, 159
-
R. Maguire, V. Pascucci, A. Maroli, J. Gulfo (1993)
Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site‐specific immunoconjugatesCancer, 72
-
Manyak (1998)
Clinical Applications of Radioimmunoscintigraphy With Prostate-Specific Antibodies for Prostate Cancer.Cancer control : journal of the Moffitt Cancer Center, 5 6
-
M. Manyak, M. Javitt (1998)
The role of computerized tomography, magnetic resonance imaging, bone scan, and monoclonal antibody nuclear scan for prognosis prediction in prostate cancer.Seminars in urologic oncology, 16 3
-
M. Haseman, N. Reed, Seth Rosenthal (1996)
Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation.Clinical nuclear medicine, 21 9
-
D. Kahn, Richard Williams, M. Haseman, N. Reed, Sara Miller, J. Gerstbrein (1998)
Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 1
-
J. Cadeddu, A. Partin, T. DeWeese, P. Walsh (1998)
Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy.The Journal of urology, 159 1
-
H. Lamb, D. Faulds (1998)
Capromab PendetideDrugs & Aging, 12
-
D. Fang, R. Stock, N. Stone, B. Krynyckyi, C. Kim, J. Machac (2000)
Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.Techniques in urology, 6 2
-
JD Petronis, F Regan, K Lin (1998)
Indium‐111 capromab pendetide (capromab pendetide) imaging to detect recurrent and metastatic prostate cancer, 23
-
D. Sodee, N. Malguria, P. Faulhaber, M. Resnick, James Albert, G. Bakale (2000)
Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers.Urology, 56 6
-
S. Krämer, J. Görich, H. Gottfried, P. Riska, A. Aschoff, N. Rilinger, H. Brambs, R. Sokiranski (1997)
Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy.The British journal of radiology, 70 838
-
J. Petronis, F. Regan, K. Lin (1998)
Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer.Clinical nuclear medicine, 23 10
-
A. Partin, A. Partin, C. Pound, C. Pound, J. Pearson, J. Pearson, J. Clemens, J. Clemens, P. Landis, P. Landis, J. Epstein, J. Epstein, H. Carter, H. Carter, P. Walsh, P. Walsh (1994)
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.Urology, 43 5
-
RT Maguire, VL Pascucci, AN Maroli, JV Gulfo (1993)
Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer, 72
-
D. Sodee, R. Ellis, M. Samuels, J. Spirnak, Wayne Poole, Clifford Riester, Dawn Martanovic, Robert Stonecipher, E. Bellon (1998)
Prostate cancer and prostate bed SPECT imaging with ProstaScint®: Semiquantitative correlation with prostatic biopsy resultsThe Prostate, 37
-
A. Partin, M. Kattan, E. Subong, P. Walsh, K. Wojno, J. Oesterling, P. Scardino, J. Pearson (1997)
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.JAMA, 277 18
-
M. Manyak, G. Hinkle, J. Olsen, Richard Chiaccherini, A. Partin, S. Piantadosi, John Burgers, J. Texter, C. Neal, J. Libertino, George Wright, R. Maguire (1999)
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.Urology, 54 6
-
CR Pound, AW Partin, JI Epstein, PC Walsh (1997)
PSA following anatomical radical retropubic prostatectomy: patterns of recurrence and cancer control, 24
-
P. Levesque, P. Nieh, L. Zinman, D. Seldin, J. Libertino (1998)
Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy.Urology, 51 6
-
C. Pound, A. Partin, J. Epstein, P. Walsh (1997)
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.The Urologic clinics of North America, 24 2
-
Daniel Kahn, Daniel Kahn, Daniel Kahn, Richard Williams, Richard Williams, Richard Williams, D. Seldin, D. Seldin, D. Seldin, J. Libertino, J. Libertino, J. Libertino, Mark Hirschhorn, Mark Hirschhorn, Mark Hirschhorn, R. Dreicer, R. Dreicer, R. Dreicer, George Weiner, George Weiner, George Weiner, David Bushnell, David Bushnell, David Bushnell, Joseph Gulfo, Joseph Gulfo, Joseph Gulfo (1994)
Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence.The Journal of urology, 152 5 Pt 1
-
R. Peschel, T. Robnett, David Hesse, C. King, R. Ennis, P. Schiff, L. Wilson (2000)
PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patientsInternational Journal of Cancer, 90
-
T. Polascik, J. Oesterling, A. Partin (1999)
Prostate specific antigen: a decade of discovery--what we have learned and where we are going.The Journal of urology, 162 2
-
G. Murphy, A. Elgamal, M. Troychak, G. Kenny (2000)
Follow‐up ProstaScint® scans verify detection of occult soft‐tissue recurrence after failure of primary prostate cancer therapyThe Prostate, 42
-
A. Elgamal, M. Troychak, G. Murphy (1998)
ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.The Prostate, 37 4
-
G. Hinkle, John Burgers, C. Neal, J. Texter, D. Kahn, Richard Williams, R. Maguire, B. Rogers, J. Olsen, R. Badalament (1998)
Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium‐111 capromab pendetideCancer, 83
-
C. Pound, A. Partin, M. Eisenberger, Daniel Chan, J. Pearson, P. Walsh (1999)
Natural history of progression after PSA elevation following radical prostatectomy.JAMA, 281 17
-
G. Murphy, R. Maguire, B. Rogers, A. Partin, W. Nelp, M. Troychak, H. Ragde, G. Kenny, R. Barren, V. Bowes, A. Gregorakis, E. Holmes, A. Boynton (1997)
Comparison of serum PSMA, PSA levels with results of cytogen‐356 ProstaScint® scanning in prostatic cancer patientsThe Prostate, 33
-
M. Haseman, Seth Rosenthal, T. Polascik (2000)
Capromab Pendetide imaging of prostate cancer.Cancer biotherapy & radiopharmaceuticals, 15 2
-
M. Seltzer, Z. Barbaric, A. Belldegrun, J. Naitoh, F. Dorey, M. Phelps, S. Gambhir, C. Hoh (1999)
Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.The Journal of urology, 162 4
-
F. Vicini, E. Ziaja, L. Kestin, Donald Brabbins, J. Stromberg, Jose Gonzalez, Alvaro Martinez (1999)
Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.Urology, 54 1
-
J. Obrecht (1977)
[Cancer therapy].Deutsche medizinische Wochenschrift, 102 8
-
M. Cher, F. Bianco, J. Lam, L. Davis, D. Grignon, W. Sakr, Mousumi Banerjee, J. Pontes, D. Wood (1998)
Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.The Journal of urology, 160 4
-
J. Moul (2000)
Prostate specific antigen only progression of prostate cancer.The Journal of urology, 163 6
-
CT Thomas, JE Montie, HS Sandler, KR Zasadny, RA Wahl (2000)
Evaluation of agreement rates between radionuclide bone scintigraphy and radioimmunoscintigraphy with indium‐111‐capromab pendetide (ProstaScint) in patients with rising PSA after definitive prostate cancer treatment -
G. Hinkle, John Burgers, J. Olsen, Bonnie Williams, R. Lamatrice, R. Barth, B. Rogers, R. Maguire (1998)
Prostate cancer abdominal metastases detected with indium-111 capromab pendetide.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 39 4
-
C. Tempany, Xiaoping Zhou, E. Zerhouni, M. Rifkin, L. Quint, C. Piccoli, J. Ellis, B. McNeil (1994)
Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques.Radiology, 192 1
-
J. Burgers, G. Hinkle, M. Haseman (1995)
Monoclonal antibody imaging of recurrent and metastatic prostate cancer.Seminars in urology, 13 2
-
G. Murphy, P. Snow, J. Brandt, A. Elgamal, M. Brawer (2000)
Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint® scintiscansThe Prostate, 42
-
J. Oesterling (1991)
Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.The Journal of urology, 145 5
-
Rodney Ellis, Edward Kim, Ridgely Conant, D. Sodee, J. Spirnak, K. Dinchman, Sam Beddar, Barry Wessels, Martin Resnick, T. Kinsella (2001)
Radioimmunoguided imaging of prostate cancer foci with histopathological correlation.International journal of radiation oncology, biology, physics, 49 5
-
A. Merrie, Md. Hasan, J. McCall (1999)
Long term follow‐up and late complications of 2‐chlorodeoxyadenosine in previously treated, advanced, indolent non‐Hodgkin's lymphomaCancer, 85
-
George Wright, C. Haley, M. Beckett, P. Schellhammer (1995)
Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.Urologic oncology, 1 1
-
A. Partin, C. Pound, J. Clemens, J. Epstein, Patrick Walsh (1993)
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.The Urologic clinics of North America, 20 4
-
K. Gill, A. Chapman, M. Weston (1997)
The changing face of emphysematous cholecystitis.The British journal of radiology, 70 838
-
F. Badellino, N. Bander, D. Kahn, C. Llorente, F. Pagano, E. Varenhorst (1998)
Capromab Pendetide A Review of its Use as an Imaging Agent in Prostate Cancer
- Publisher
- Wiley
- Copyright
- Copyright © 2002 Wiley Subscription Services, Inc., A Wiley Company
- ISSN
- 0008-543X
- eISSN
- 1097-0142
- DOI
- 10.1002/cncr.10337
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Cancer – Wiley
Published: Mar 15, 2003
Keywords: ; ; ; ; ;